Treating pruritus. What's new in safe relief of symptoms?
In several cutaneous disorders, pruritus is both the primary symptom and the cause of perpetuating factor. Therefore, one focus of therapy should be on treating pruritus and thereby preventing or aiding in the resolution of skin lesions. Several treatment options are available, including nonpharmacologic methods; use of emollients, tar preparations, and other topical agents; ultraviolet B therapy; and use of oral antihistamines or corticosteroids. A new topical tricyclic agent is now available that adds a promising therapeutic approach.
Department of Dermatology, Tulane University School of Medicine, New Orleans, USA.
L E
LE
Millikan
D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000982:Antipruritics / Q000627:therapeutic use*; D004316:Doxepin / Q000008:administration & dosage; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D011537:Pruritus / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology / Q000628:therapy
D000305:Adrenal Cortex Hormones; D000982:Antipruritics; D006634:Histamine H1 Antagonists; D004316:Doxepin